Works Cited

Oral and Maxillofacial Infections

Course #54032 - $35 • 5 Hours/Credits

  • Back to Course Home
  • Participation Instructions
    • Review the course material online or in print.
    • Complete the course evaluation.
    • Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.

1. Grinde B, Olsen I. The role of viruses in oral disease. J Oral Microbiol. 2010;2:2127.

2. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005;43(11): 5721-5732.

3. Krishnan PA. Fungal infections of the oral mucosa. Indian J Dental Res. 2012;23(5):650-659.

4. Fabian TK, Fejerdy P, Csermely P. Saliva in health and disease. In: Begley TP (ed). Wiley Encyclopedia of Chemical Biology. Hoboken, NJ: John Wiley and Sons, Inc; 2008: 1-9.

5. Brandtzaeg P. Do salivary antibodies reliably reflect both mucosal and systemic immunity? Ann NY Acad Sci. 2007;1098:288-311.

6. Brodgen KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005;3(3):238-250.

7. Li XS, Sun JN, Okamoto-Shibayama K, Edgerton M. Candida albicans cell wall Ssa proteins bind and facilitate import of salivary histatin 5 required for toxicity. J Biol Chem. 2006;281(32):22453-22463.

8. Fabian TK, Hermann P, Beck A, Fejerdy P, Fabian G. Salivary defense proteins: their network and role in innate and acquired oral immunity. Int J Mol Sci. 2012;13(4):4295-4320.

9. Gregoire C. How are odontogenic infections best managed? J Can Dent Assoc. 2010;76:a37.

10. Harp JR, Ellis E III, Tucker MR. Contemporary Oral and Maxillofacial Surgery. 7th ed. Philadelphia, PA: Elsevier; 2019.

11. Miliro M, Ghali GE, Larsen PE, Waite P. Peterson's Principles of Oral and Maxillofacial Surgery. 3rd ed. Shelton, CT: People's Medical Publishing House; 2012.

12. Dennis MJ. Treating odontogenic infections: an update for dental professionals. J Mich Dent Assoc. 2006;8(11):20-25.

13. Sequra-Eqea JJ, Martin-Gonzalez J, Jimenez-Sanchez MDC, Crespo-Gallardo I, Sauco-Marquez JJ, Velasco-Ortega E. Worldwide pattern of antibiotic prescription in endodontic infections. Int Dent J. 2017;67(4):197-205.

14. Munoz-Price LS, Jacoby GA. Extended-Spectrum Beta-Lactamases. Available at https://www.uptodate.com/contents/extended-spectrum-beta-lactamases. Last accessed May 28, 2020.

15. Drwaz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev. 2010;23(1):160-201.

16. Cotter G, Kavanagh K. Adherence mechanism of Candida albicans. Br J Biomed Sci. 2000;57(3):241-249.

17. Hoyer LL. The ALS gene family of Candida albicans. Trends Microbiol. 2001;9(4):176-180.

18. Staab JF, Bradway SD, Fidel PL, Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science. 1999;283(5407):1535-1538.

19. Raju SB, Rajappa S. Isolation and identification of Candida from the oral cavity. ISRN Dent. 2011;2011:487921.

20. Marsh PD, Martin M. Oral Microbiology. Edinburgh: Churchill Livingstone; 2009.

21. Slots J. Oral viral infections of adults. Periodontology. 2009;49:60-86.

22. Akhter K. Cytomegalovirus. Available at https://emedicine.medscape.com/article/215702-overview. Last accessed May 28, 2020.

23. Pellett PE, Roizman B. The family Herpesviridae: a brief introduction. In: Knipe DM, Howley PM (eds). Fields Virology. 6th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2013: 1802-1822.

24. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006:31(4):259-266.

25. Howley PM, Schiler JT, Lowy DR. Papillomaviruses. In: Knipe DM, Howley PM (eds). Fields Virology. 6th ed. Philadelphia: Lipincott, Williams and Wilkins; 2013: 1662-1703.

26. National Institutes of Health. Dental Caries (Tooth Decay). Available at https://www.nidcr.nih.gov/DataStatistics/FindDataByTopic/DentalCaries. Last accessed May 28, 2020.

27. Piris-Lopez R, Aguilar L, Gimenez MJ. Management of odontogenic infections of pulpal and periodontal origin. Med Oral Patol Oral Cir Bucal. 2007;12(2):e154-e159.

28. Robertson D, Smith A.J. The microbiology of the acute dental abscess. J Med Microbiol. 2009;58(2):155-162.

29. Patel PV, Kumar SG, Patel A. Periodontal abscess: a review. J Clin Diagnostic Res. 2011;5(2):404-409.

30. Jaramillo A, Arce RM, Herrera D, Betancourth M, Botero JE, Contreras A. Clinical and microbiological characterization of periodontal abscesses. J Clin Periodontol. 2005;32(12):1213-1218.

31. Herrera D, Roldan S, Gonzalez I, Sanz M. The periodontal abscess (I): clinical and microbiological findings. J Clin Periodontol. 2000;27(6):387-394.

32. Prato-Pini G, Magnani C, Rotundo R. Treatment of acute periodontal abscesses using the biofilm decontamination approach: a case report study. Int J Periodontics Restorative Dent. 2016;36(1):55-63.

33. Topazian RG, Goldberg MH, Hupp JR. Oral and Maxillofacial Infections. 4th ed. New York, NY: WB Saunders Company; 2002.

34. Centers for Disease Control and Prevention. HIV: Terms, Definitions, and Calculations Used in CDC HIV Surveillance Publications. Available at http://www.cdc.gov/hiv/statistics/recommendations/terms.html. Last accessed May 28, 2020.

35. Tyring S. Mucosal Immunology and Virology. London: Springer-Verlag; 2006.

36. Portela MB, Cerqueeira DF, Soares RMA, Castro GF. Candida spp. in linear gingival erythema lesions in HIV-infected children: reports of six cases. Int J Science Dentistry. 2012;1(37):51-55.

37. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4(1):1-6.

38. Todescan S, Nizar R. Managing patients with necrotizing ulcerative periodontitis. J Can Dent Assoc. 2013;79:d44.

39. Feller L, Lemmer J. Necrotizing gingivitis as it relates to HIV infection: a review of the literature. Perio Pract Today. 2005;2(1): 31-37.

40. Patton LL. The ADA Practical Guide to Patients with Medical Conditions. 2nd. Hoboken, NJ: Wiley & Sons, Inc.; 2016.

41. Laskin DM. Clinician's Handbook of Oral and Maxillofacial Surgery. 2nd ed. Hanover Park, IL: Quintessence Publishing Com Inc; 2019.

42. American Dental Association. ADA/PDR Guide to Dental Therapeutics. 5th ed. Montvale, NJ: Physicians' Desk Reference, Inc.; 2009.

43. Wynn RL, Meiller TF, Crossley HL. Drug Information Handbook for Dentistry. 25th ed. Hudson, OH: Lexicomp; 2019.

44. Chunduri NS, Madasu K, Goteci VR, Karpe T, Reddy H. Evaluation of bacterial spectrum or orofacial infections and their antibiotic susceptibility. Ann Maxillofac Surg. 2012;2(1):46-50.

45. Geddes AM, Klugman KP, Rolinson GN. Introduction: historical perspective and development of amoxicillin/clavulanate.Int J Antimicrob Agents. 2007;30(2):S109-S112.

46. Newman MG, van Winkelhoff AJ. Antibiotic and Antimicrobial Use in Dental Practice. 2nd ed. Carol Stream, IL: Quintessence Publishing Co, Inc.; 2001.

47. Little JW, Falace Donald L, Miller CS, Rhodus NL. Dental Management of the Medically Compromised Patient. 9th ed. St. Louis, MO: Mosby Elsevier; 2018.

48. eMedExpert. Azithromycin (Zithromax). Available at https://www.emedexpert.com/facts/azithromycin-facts.shtml. Last accessed May 28, 2020.

49. Scully C. Mucosal Candidiasis. Available at https://emedicine.medscape.com/article/1075227-overview. Last accessed May 28, 2020.

50. Reichart PA, Samaranayake LP and Philipsen HP. Pathology and clinical correlates in oral candidiasis and its variants: a review. Oral Dis. 2000;6:85-91.

51. Mukherjee PK, Chen H, Patton LL, et al. Topical gentian violet compared to nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1 infected participants. AIDS. 2017;31(1):81-88.

52. Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-e50.

53. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002;50(4):243-260.

54. Scully C. Noncandidal Fungal Infections of the Mouth. Available at https://emedicine.medscape.com/article/1077685-overview. Last accessed May 28, 2020.

55. Beyki A, Zardast M, Nasrollahi Z. Maxillary sinus aspergillosis: a case report of the timely failure to treatment. Iran J Microbiol. 2019;11(4):345-348.

56. MedlinePlus. Herpes – Oral. Available at https://medlineplus.gov/ency/article/000606.htm. Last accessed May 28, 2020.

57. Ayoade FO. Herpes Simplex. Available at https://emedicine.medscape.com/article/218580-overview#a4. Last accessed May 28, 2020.

58. Dronen SC. Herpetic Whitlow. Available at https://emedicine.medscape.com/article/788056-overview. Last accessed May 28, 2020.

59. Anderson WE. Varicella-Zoster Virus. Available at https://emedicine.medscape.com/article/231927-overview. Last accessed May 28, 2020.

60. Centers for Disease Control and Prevention. Shingles (Herpes Zoster): Treating Shingles. Available at https://www.cdc.gov/shingles/about/prevention-treatment.html. Last accessed May 28, 2020.

61. Cade JE. Hairy Leukoplakia. Available at https://emedicine.medscape.com/article/279269-overview. Last accessed May 28, 2020.

62. zur Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Physicians. 1999;111(6):581-587.

63. Eversole LR. Papillary lesions of the oral cavity: relationship to human papillomaviruses. J Calif Dent Assoc. 2000;28(12):922-927.

64. Scully C, Epstein J, Porter S, Cox M. Viruses and chronic disorders involving the human oral mucosa. Oral Surg Oral Med Oral Pathol. 1991;72(5):537-544.

65. Ghadishah D. Genital Warts. Available at https://emedicine.medscape.com/article/763014-overview. Last accessed May 28, 2020.

66. Kellokoski J, Syrjanen S, Syrjanen K, Yliskoski M. Oral mucosal changes in women with genital HPV infection. J Oral Pathol Med. 1990;19(3):142-148.

67. Silverman S Jr. Color Atlas of Oral Manifestations of AIDS. 2nd ed. St. Louis, MO: Mosby, Inc.; 1996.

68. Eversole LR, Laipis PJ. Oral squamous papillomas: detection of HPV DNA by in situ hybridization. Oral Surg Oral Med Oral Pathol. 1988;65(5):545-550.

69. Scully C, Flint SR, Porter SR. Oral Diseases. 2nd ed. St. Louis, MO: Mosby, Inc.; 1996.

70. Ghalayani P, Tavakoli P, Eftekhari M, Haghighi MA. Oral focal epithelial hyperplasia: report of three cases. Turk Patoloji Derg. 2015;31(1):880-83.

71. Harris AM, van Wyk CW. Heck's disease (focal epithelial hyperplasia): a longitudinal study. Community Dent Oral Epidemiol. 1993;21(2):82-85.

72. Padayachee A, van Wyk CW. Human papillomavirus (HPV) DNA in focal epithelial hyperplasia by in situ hybridization. J Oral Pathol Med. 1991;20(5):210-214.

73. DermNet New Zealand. Focal Epithelial Hyperplasia. Available at https://www.dermnetnz.org/topics/focal-epithelial-hyperplasia. Last accessed May 28, 2020.

  • Back to Course Home
  • Participation Instructions
    • Review the course material online or in print.
    • Complete the course evaluation.
    • Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.